The global transplantation market size is expected to reach USD 32.94 Billion in 2032 and register a revenue CAGR of 11.5% during the forecast period.
Key Pointers
- Tissue product segment accounted for largest revenue share in 2022.
- Immunosuppressive drugs segment revenue is expected to register a steady growth rate during the forecast period.
- the global transplantation market is segmented into organ transplant and tissue transplant.Organ transplant segment accounted for largest revenue share in 2022.
- Tissue transplant segment revenue is expected to register a steady growth rate during the forecast period.
- Hospital segment accounted for largest revenue share in 2022.
- Transplant centers segment is expected to register a steady revenue growth rate during the forecast period,
- Based on regional analysis, transplantation market in North America accounted for largest revenue share in 2022.
Request a Sample@ https://www.qyresearchmedical.com/sample/119579
Report Scope of the Transplantation Market:
| Report Coverage | Details |
| The market size value in 2022 | USD 12.30 Billion |
| CAGR (2023 – 2032) | 11.5% |
| The Revenue forecast in 2032 | USD 32.94 Billion |
| Quantitative units |
|
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Increases cases of organ failure, is resulting in rising demand for tissue transplantation and organ transplantation products, which is a major factor driving global transplantation market revenue growth.
One of the most significant advancements in modern medicine is organ transplantation. It is a medical technique in which an organ or tissue is surgically removed from one person (the organ donor) and implanted into another person (the organ recipient). Organ transplants cannot be performed without consent of the patient or without consent of the patient family and if done, it is considered illegal or a crime.
Major factors driving the transplantation market revenue growth are increased consumption of alcohol and other harmful substances, as well as an unhealthy lifestyle, resulting in gradual damage of organs. Cardiovascular disease, diabetes, cancer, renal illness, and Alzheimer’s disease, among others, affect a huge section of the world’s population and can lead to organ and tissue failure.
Human organs such as kidney, lung, liver, pancreas, cornea, and skin can be transplanted. Transplants aid in the restoration of a healthy body and help the patient live a healthy lifestyle. Technological advancements help in improving the success rate of transplants. Furthermore, advanced software and systems make tissue and organ preservation more convenient.
Growing adoption of tissue and organ transplantation due to continuous development of more advanced surgical technologies, improved healthcare infrastructure, and increased awareness about organ donation. Growing number of tissue banks, as well as development of technologically advanced devices are driving revenue growth of the market. In the transplantation industry, evolvement of innovative 3D printing technology designed to create an organ/tissue that is similar to the one within the body is expected to drive revenue growth of the market. In addition, programs and campaigns by government of various countries across the world, such as donation campaigns to raise awareness about organ donation, is resulting in increasing number of organ donors.
However, there is a significant gap between demand for organ transplantation and availability of human organs and tissue, which is mostly due to lack of education and knowledge about organ donation, as well as religious myths, that could limit market revenue growth.
Competitive Landscape
Competitive landscape of the global transplantation market is consolidated with few key players operating on global and regional levels. Key players are engaged in product development and strategic alliances to expand their respective product portfolio and gain a robust footing in the global market. Major players in the market include Veloxis Pharmaceuticals, Inc., Abbott, Becton, Dickinson, and Company (BD), bioMérieux SA, Bio-Rad Laboratories, Inc., CareDx, Inc., F. Hoffmann-La Roche Ltd, Hologic, Inc, Illumina, Inc., and QIAGEN.
Transplantation Market Segmentations:
| By Product | By Wound Type | By End-use | Regional scope |
| Tissue Products
Immunosuppressive Drugs Preservation Solutions |
Organ Transplant
Tissue Transplant |
Hospital
Transplant Center Others |
North America
Europe Asia Pacific Latin America Middle East & Africa |
Buy quantitative research Report at discounted price – USD 1599 https://www.qyresearchmedical.com/report/checkout/119579/
You can place an order or ask any questions, please feel free to contact [email protected] | +1 9197 992 333
Blog: https://www.novaoneadvisor.com/
Blog: https://www.visionresearchreports.com/
About Us
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us:
URL – http://www.qyresearchmedical.com/
https://www.linkedin.com/company/qyresearch-medical/
https://www.facebook.com/QYResearch-Medical-108186514228917/